1320 related items for PubMed ID: 22902358
41. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
Cannavò S, Almoto B, Dall'Asta C, Corsello S, Lovicu RM, De Menis E, Trimarchi F, Ambrosi B.
Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
[Abstract] [Full Text] [Related]
42. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J, Knappe UJ, Lüdecke DK.
Zentralbl Neurochir; 2003 Sep; 64(1):6-11. PubMed ID: 12582940
[Abstract] [Full Text] [Related]
43. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
Hameed N, Yedinak CG, Brzana J, Gultekin SH, Coppa ND, Dogan A, Delashaw JB, Fleseriu M.
Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
[Abstract] [Full Text] [Related]
44. Early Basal Cortisol Level as a Predictor of Hypothalamic-Pituitary-Adrenal (HPA) Axis Function After Pituitary Tumor Surgery.
Polovina TS, Kraljevic I, Solak M, Balasko A, Haxhiu A, Haxhiu A, Dusek T, Poljicanin T, Kastelan D.
Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):709-714. PubMed ID: 31091548
[Abstract] [Full Text] [Related]
45. Perioperative management of the hypothalamic-pituitary-adrenal axis in patients with pituitary adenomas: an Australasian survey.
Joseph SP, Ho JT, Doogue MP, Burt MG.
Intern Med J; 2012 Oct; 42(10):1120-4. PubMed ID: 21883779
[Abstract] [Full Text] [Related]
46. Recurrences of ACTH-secreting adenomas after pituitary adenomectomy can be accurately predicted by perioperative measurements of plasma ACTH levels.
Abdelmannan D, Chaiban J, Selman WR, Arafah BM.
J Clin Endocrinol Metab; 2013 Apr; 98(4):1458-65. PubMed ID: 23450054
[Abstract] [Full Text] [Related]
47. Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary.
Wentworth JM, Gao N, Sumithran KP, Maartens NF, Kaye AH, Colman PG, Ebeling PR.
Clin Endocrinol (Oxf); 2008 Jan; 68(1):29-35. PubMed ID: 18088287
[Abstract] [Full Text] [Related]
48. Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.
Pimentel-Filho FR, Silva ME, Nogueira KC, Berger K, Cukiert A, Liberman B.
J Endocrinol Invest; 2005 Jun; 28(6):502-8. PubMed ID: 16117190
[Abstract] [Full Text] [Related]
49. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F.
J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
[Abstract] [Full Text] [Related]
50. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[Abstract] [Full Text] [Related]
51. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.
Jahangiri A, Wagner JR, Han SW, Tran MT, Miller LM, Chen R, Tom MW, Ostling LR, Kunwar S, Blevins L, Aghi MK.
J Neurosurg; 2016 Mar; 124(3):589-95. PubMed ID: 26252454
[Abstract] [Full Text] [Related]
52. Long-term surgical outcomes following transsphenoidal surgery in patients with Rathke's cleft cysts.
Lin M, Wedemeyer MA, Bradley D, Donoho DA, Fredrickson VL, Weiss MH, Carmichael JD, Zada G.
J Neurosurg; 2018 May 18; 130(3):831-837. PubMed ID: 29775155
[Abstract] [Full Text] [Related]
53. Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: outcomes with Cushing's disease.
Sarkar S, Rajaratnam S, Chacko G, Mani S, Hesargatta AS, Chacko AG.
Acta Neurochir (Wien); 2016 Jan 18; 158(1):77-86; discussion 86. PubMed ID: 26577636
[Abstract] [Full Text] [Related]
54. Serum cortisol response to transsphenoidal surgery for Cushing disease.
Simmons NE, Alden TD, Thorner MO, Laws ER.
J Neurosurg; 2001 Jul 18; 95(1):1-8. PubMed ID: 11453376
[Abstract] [Full Text] [Related]
55. Rapid assessment of corticotropin reserve after pituitary surgery.
Watts NB, Tindall GT.
JAMA; 1988 Feb 05; 259(5):708-11. PubMed ID: 2826832
[Abstract] [Full Text] [Related]
56. Outcome of Microscopic Transsphenoidal Surgery in Cushing Disease: A Case Series of 96 Patients.
Shirvani M, Motiei-Langroudi R, Sadeghian H.
World Neurosurg; 2016 Mar 05; 87():170-5. PubMed ID: 26704208
[Abstract] [Full Text] [Related]
57. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
Neurosurg Focus; 2010 Oct 05; 29(4):E6. PubMed ID: 20887131
[Abstract] [Full Text] [Related]
58. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test.
Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U.
Clin Endocrinol (Oxf); 2005 Nov 05; 63(5):499-505. PubMed ID: 16268800
[Abstract] [Full Text] [Related]
59. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
Ronchi CL, Ferrante E, Rizzo E, Giavoli C, Verrua E, Bergamaschi S, Lania AG, Beck-Peccoz P, Spada A.
Clin Endocrinol (Oxf); 2008 Oct 05; 69(4):608-12. PubMed ID: 18410544
[Abstract] [Full Text] [Related]
60. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH.
J Neurosurg; 2003 May 05; 98(5):967-73. PubMed ID: 12744355
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
